Literature DB >> 2469527

Choroidal neovascularization and central serous chorioretinopathy.

J E Gomolin1.   

Abstract

Three forms of choroidal neovascularization may occur associated with central serous chorioretinopathy (CSC). Two have previously been reported and are briefly reviewed. The author presents a third, previously unreported pattern of choroidal neovascularization complicating untreated recurrent CSC.

Entities:  

Mesh：

Year:  1989        PMID： 2469527

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN： 0008-4182            Impact factor:   1.882


  11 in total

1.  [Central serous chorioretinopathy (CSC)].

Authors:  H Baraki; N Feltgen; J Roider; H Hoerauf; C Klatt
Journal:  Ophthalmologe       Date:  2010-05       Impact factor: 1.059

2.  Alterations in "in vivo" histology of retina in bilateral chronic central serous chorioretinopathy after intravitreal bevacizumab.

Authors:  Sandeep Saxena; Astha Jain
Journal:  J Ocul Biol Dis Infor       Date:  2012-03-08

3.  Association of Choroidal Neovascularization and Central Serous Chorioretinopathy With Optical Coherence Tomography Angiography.

Authors:  Marco Antonio Bonini Filho; Talisa E de Carlo; Daniela Ferrara; Mehreen Adhi; Caroline R Baumal; Andre J Witkin; Elias Reichel; Jay S Duker; Nadia K Waheed
Journal:  JAMA Ophthalmol       Date:  2015-08       Impact factor: 7.389

4.  Therapeutic benefit of melatonin in refractory central serous chorioretinopathy.

Authors:  A L Gramajo; G E Marquez; V E Torres; C P Juárez; R E Rosenstein; J D Luna
Journal:  Eye (Lond)       Date:  2015-07-10       Impact factor: 3.775

5.  En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy.

Authors:  Daniela Ferrara; Kathrin J Mohler; Nadia Waheed; Mehreen Adhi; Jonathan J Liu; Ireneusz Grulkowski; Martin F Kraus; Caroline Baumal; Joachim Hornegger; James G Fujimoto; Jay S Duker
Journal:  Ophthalmology       Date:  2013-11-26       Impact factor: 12.079

6.  Short-term efficacy of intravitreal dobesilate in central serous chorioretinopathy.

Authors:  Pedro Cuevas; Luis A Outeiriño; Carlos Azanza; Javier Angulo; Guillermo Giménez-Gallego
Journal:  Eur J Med Res       Date:  2012-07-12       Impact factor: 2.175

7.  Factors influencing the visual acuity of chronic central serous chorioretinopathy.

Authors:  Yun Young Kim; Christina J Flaxel
Journal:  Korean J Ophthalmol       Date:  2011-03-11

8.  Intravitreal bevacizumab for subfoveal choroidal neovascularization complicating active central serous chorioretinopathy.

Authors:  Subrata Mandal; Subijay Sinha; Zahir Abbas; Pradeep Venkatesh
Journal:  Indian J Ophthalmol       Date:  2011 Jul-Aug       Impact factor: 1.848

9.  Optical coherence tomography angiography versus fluorescein angiography in diagnosing choroidal neovascularization in chronic central serous chorioretinopathy.

Authors:  Reema Bansal; Mohit Dogra; Samyak Mulkutkar; Deeksha Katoch; Ramandeep Singh; Vishali Gupta; Mangat Ram Dogra; Amod Gupta
Journal:  Indian J Ophthalmol       Date:  2019-07       Impact factor: 1.848

10.  Novel insights into retinal neovascularization secondary to central serous chorioretinopathy using 3D optical coherence tomography angiography.

Authors:  Markus Gruber; Julian Wolf; Andreas Stahl; Thomas Ness; Henrik Scholl; Hansjuergen Agostini; Peter Maloca; Clemens Lange
Journal:  Am J Ophthalmol Case Rep       Date:  2020-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.